Eticovo

Product NDC
71202-004
11-digit product format
712020004
Labeler code
71202
Product ID
71202-004_d2d6f14e-fdc3-46ab-b84b-4b17d3bea8f0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
etanercept
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Samsung Bioepis Co., Ltd.
Application
BLA761066
Marketing category
BLA
Marketing start
2020-10-31
Marketing end
0000-00-00
Substance
ETANERCEPT
Active strength
25 mg/.5mL
Pharmacologic classes
Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct71202-004DDiscontinued by firm2026-07-31
excluded packagepackage71202-00471202-004-04DDiscontinued by firm2026-07-31

FDA-Initiated Inactive NDC Indexing#

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761066Eticovoetanercept-ykro351(k) InterchangeableDisc2026-06-01